share_log

Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives Consensus Rating of "Moderate Buy" From Brokerages

Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives Consensus Rating of "Moderate Buy" From Brokerages

Intuitive Surgical, Inc.(纳斯达克股票代码:ISRG)获得经纪商的 “适度买入” 共识评级
Defense World ·  2023/02/02 16:51

Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) has received a consensus recommendation of "Moderate Buy" from the twenty-two analysts that are presently covering the firm, Marketbeat Ratings reports. Four analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $276.53.

据MarketBeat Ratings报道,纳斯达克(代码:ISRG-GET Rating)已收到目前追踪该公司的22位分析师一致提出的“适度买入”的建议。4名分析师对该股的评级为持有,13名分析师对该公司的评级为买入。过去一年对该股进行评级的分析师的平均12个月目标价为276.53美元。

ISRG has been the subject of a number of recent research reports. Piper Sandler boosted their price objective on Intuitive Surgical from $260.00 to $265.00 and gave the company an "overweight" rating in a research note on Wednesday, October 19th. Barclays boosted their price target on Intuitive Surgical from $235.00 to $298.00 in a report on Wednesday, January 4th. StockNews.com assumed coverage on Intuitive Surgical in a report on Wednesday, October 12th. They issued a "hold" rating on the stock. Morgan Stanley decreased their price objective on Intuitive Surgical from $290.00 to $265.00 and set an "equal weight" rating on the stock in a report on Wednesday, January 25th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on Intuitive Surgical from $230.00 to $245.00 in a report on Wednesday, January 25th.

ISRG是最近一些研究报告的主题。派珀·桑德勒将直觉外科公司的目标股价从260.00美元上调至265.00美元,并在10月19日(周三)的一份研究报告中给予该公司“增持”评级。巴克莱在1月4日周三的一份报告中将直觉外科公司的目标价从235.00美元上调至298.00美元。斯托克新闻网在10月12日星期三的一篇报道中报道了直觉外科公司。他们对该股的评级为“持有”。摩根士丹利在1月25日周三的一份报告中将直觉外科公司的目标价从290.00美元下调至265.00美元,并对该股设定了“同等权重”的评级。最后,德意志银行在1月25日周三的一份报告中将直觉外科公司的目标价从230.00美元上调至245.00美元。

Get
到达
Intuitive Surgical
直觉外科公司
alerts:
警报:

Intuitive Surgical Stock Performance

直觉外科公司股票表现

NASDAQ ISRG opened at $251.19 on Thursday. Intuitive Surgical has a one year low of $180.07 and a one year high of $308.97. The stock has a 50-day moving average of $263.32 and a 200 day moving average of $235.62. The company has a market capitalization of $88.77 billion, a price-to-earnings ratio of 68.63, a PEG ratio of 4.80 and a beta of 1.36.

纳斯达克周四开盘价为251.19美元。直觉外科公司的一年低点为180.07美元,一年高位为308.97美元。该股的50日移动均线切入位在263.32美元,200日移动均线切入位在235.62美元。该公司市值887.7亿美元,市盈率为68.63倍,聚乙二醇率为4.80倍,贝塔系数为1.36。

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last released its quarterly earnings data on Tuesday, January 24th. The medical equipment provider reported $1.23 EPS for the quarter, missing the consensus estimate of $1.25 by ($0.02). The business had revenue of $1.66 billion during the quarter, compared to the consensus estimate of $1.66 billion. Intuitive Surgical had a return on equity of 11.27% and a net margin of 21.25%. Intuitive Surgical's quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.30 earnings per share. On average, equities analysts predict that Intuitive Surgical will post 4.22 earnings per share for the current fiscal year.
直觉外科公司(纳斯达克代码:ISRG-GET Rating)最近一次发布季度收益数据是在1月24日(星期二)。这家医疗设备提供商公布本季度每股收益为1.23美元,低于普遍预期的1.25美元(0.02美元)。该业务本季度营收为16.6亿美元,而市场普遍预期为16.6亿美元。直觉外科公司的股本回报率为11.27%,净利润率为21.25%。与去年同期相比,直觉外科公司的季度营收增长了6.7%。在去年同一季度,该业务公布的每股收益为1.30美元。股票分析师平均预测,直觉外科公司本财年每股收益将达到4.22欧元。

Insider Buying and Selling

内幕买卖

In other Intuitive Surgical news, EVP Robert Desantis sold 1,629 shares of the firm's stock in a transaction that occurred on Friday, January 27th. The stock was sold at an average price of $250.00, for a total value of $407,250.00. Following the sale, the executive vice president now directly owns 6,769 shares of the company's stock, valued at $1,692,250. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, Director Amal M. Johnson sold 6,375 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, November 8th. The stock was sold at an average price of $239.36, for a total transaction of $1,525,920.00. Following the transaction, the director now owns 11,224 shares in the company, valued at $2,686,576.64. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Robert Desantis sold 1,629 shares of Intuitive Surgical stock in a transaction that occurred on Friday, January 27th. The stock was sold at an average price of $250.00, for a total value of $407,250.00. Following the transaction, the executive vice president now owns 6,769 shares in the company, valued at approximately $1,692,250. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.

在直觉外科公司的另一则消息中,执行副总裁罗伯特·德桑蒂斯在1月27日(星期五)的一笔交易中出售了1,629股该公司的股票。这只股票的平均售价为250.00美元,总价值为407,250.00美元。出售股份后,执行副总裁总裁现在直接持有该公司6769股股票,价值169.22万美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可以通过美国证券交易委员会网站。在相关新闻中,董事在11月8日星期二的一笔交易中出售了6,375股直觉外科公司的股票。股票以239.36美元的平均价格出售,总成交金额为1,525,920.00美元。交易完成后,董事现在拥有该公司11,224股,价值2,686,576.64美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过这个环节。此外,执行副总裁罗伯特·德桑蒂斯在1月27日星期五的一笔交易中出售了1,629股直觉外科公司的股票。这只股票的平均售价为250.00美元,总价值为407,250.00美元。交易完成后,执行副总裁总裁现在拥有该公司6769股股份,价值约1692,250美元。关于这次销售的披露可以找到这里。0.90%的股份由企业内部人士持有。

Hedge Funds Weigh In On Intuitive Surgical

对冲基金看好直觉外科公司

A number of institutional investors have recently added to or reduced their stakes in ISRG. Vanguard Group Inc. grew its stake in shares of Intuitive Surgical by 1.0% in the third quarter. Vanguard Group Inc. now owns 29,283,566 shares of the medical equipment provider's stock valued at $5,488,912,000 after buying an additional 282,881 shares in the last quarter. BlackRock Inc. boosted its position in shares of Intuitive Surgical by 5.6% during the 3rd quarter. BlackRock Inc. now owns 27,887,777 shares of the medical equipment provider's stock worth $5,227,284,000 after acquiring an additional 1,477,885 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Intuitive Surgical by 3.3% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 25,692,735 shares of the medical equipment provider's stock worth $5,156,788,000 after acquiring an additional 816,066 shares in the last quarter. State Street Corp boosted its position in shares of Intuitive Surgical by 0.3% during the 2nd quarter. State Street Corp now owns 15,220,507 shares of the medical equipment provider's stock worth $3,054,908,000 after acquiring an additional 38,293 shares in the last quarter. Finally, Baillie Gifford & Co. boosted its position in shares of Intuitive Surgical by 1.7% during the 4th quarter. Baillie Gifford & Co. now owns 4,268,859 shares of the medical equipment provider's stock worth $1,132,742,000 after acquiring an additional 69,717 shares in the last quarter. Hedge funds and other institutional investors own 81.96% of the company's stock.

一些机构投资者最近增持或减持了ISRG的股份。先锋集团第三季度增持直觉外科公司股份1.0%。先锋集团现在拥有29,283,566股这家医疗设备供应商的股票,价值5,488,912,000美元,上个季度又购买了282,881股。贝莱德股份有限公司在第三季度将其持有的直觉外科公司股票头寸提高了5.6%。贝莱德股份有限公司现在持有这家医疗设备供应商27,887,777股股票,价值5,227,284,000美元,上个季度又购入了1,477,885股。Price T Rowe Associates Inc.MD在第二季度将其持有的直觉外科公司股票头寸增加了3.3%。Price T Rowe Associates Inc.MD现在拥有这家医疗设备提供商25,692,735股股票,价值5,156,788,000美元,上个季度又收购了816,066股。道富银行在第二季度将其持有的直觉外科公司股票头寸提高了0.3%。道富集团目前持有这家医疗设备提供商15,220,507股股票,价值3,054,908,000美元,此前该公司在上个季度额外收购了38,293股。最后,Baillie Gifford&Co.在第四季度将其持有的直觉外科公司股票头寸提高了1.7%。贝利·吉福德公司(Baillie Gifford&Co.)在上个季度增持了69,717股后,现在持有这家医疗设备供应商价值1,132,742,000美元的股票4,268,859股。对冲基金和其他机构投资者持有该公司81.96%的股票。

About Intuitive Surgical

关于直觉外科公司

(Get Rating)

(获取评级)

Intuitive Surgical, Inc engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

直觉外科公司公司从事达芬奇外科系统及相关侵入性手术器械和附件的开发、制造和营销。它的产品包括达芬奇和Ion。该公司由弗雷德里克·H·莫尔、约翰·戈登·弗洛因德和罗伯特·G·杨格于1995年11月创立,总部位于加利福尼亚州桑尼维尔。

Read More

阅读更多内容

  • Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
  • Bed Bath & Beyond Is Circling the Drain
  • Allegro Microsystems Is A Well-Positioned Semiconductor Stock
  • Scotts Miracle-Gro Hits Bottom, Reversal In Play
  • Altria is a Great Recession Stock, Long-Term Outlook Uncertain
  • Novavax Shares Jumped in January While Others Slipped
  • 免费获取斯托克新闻网关于直觉外科公司的研究报告
  • Bed Bath&Beyond正在绕着排水沟走
  • Allegro MicroSystems是一只定位良好的半导体股票
  • 斯科特奇迹-Gro触底,比赛逆转
  • 奥驰亚是一只大衰退的股票,长期前景不确定
  • Novavax的股价在1月份大幅上涨,而其他股票则出现下滑

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

接受《直觉外科公司日报》的新闻和评级-在下面输入您的电子邮件地址,即可通过MarketBeat.com的免费每日电子邮件时事通讯接收对直觉外科公司及相关公司的最新新闻和分析师评级的每日摘要。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发